These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Treatment of pain syndromes with venlafaxine. Grothe DR; Scheckner B; Albano D Pharmacotherapy; 2004 May; 24(5):621-9. PubMed ID: 15162896 [TBL] [Abstract][Full Text] [Related]
44. [Do antidepressive agents have analgesic effects?]. Fasmer OB Tidsskr Nor Laegeforen; 1990 Aug; 110(18):2370-2. PubMed ID: 2218995 [TBL] [Abstract][Full Text] [Related]
45. [Between depression and fibroniyalgia: the fate of the antidepressant]. Drobizhev MY; Fedotova AV; Kikta SV; Antokhin EY Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):114-120. PubMed ID: 27386594 [TBL] [Abstract][Full Text] [Related]
46. Physical symptoms of depression: unmet needs in special populations. Stewart DE J Clin Psychiatry; 2003; 64 Suppl 7():12-6. PubMed ID: 12755647 [TBL] [Abstract][Full Text] [Related]
47. Does depression hurt? Stahl SM J Clin Psychiatry; 2002 Apr; 63(4):273-4. PubMed ID: 12000200 [TBL] [Abstract][Full Text] [Related]
48. Antidepressants as analgesics. McCleane G CNS Drugs; 2008; 22(2):139-56. PubMed ID: 18193925 [TBL] [Abstract][Full Text] [Related]
49. Duloxetine use in painful conditions. Marcus DA Expert Opin Pharmacother; 2011 Jun; 12(8):1333-1340. PubMed ID: 21548724 [No Abstract] [Full Text] [Related]
50. Moving beyond balance for a better antidepressant. Botts S Am J Health Syst Pharm; 2005 Dec; 62(23):2479. PubMed ID: 16303902 [No Abstract] [Full Text] [Related]
51. LEVOMILNACIPRAN--A SUCCESSOR OF MILNACIPRAN WITH A HIGHER NORADRENERGIC SELECTIVITY. Zadka Ł; Dziwota E; Olajossy M Acta Pol Pharm; 2016; 73(2):285-9. PubMed ID: 27180420 [TBL] [Abstract][Full Text] [Related]
52. Coping with somatic comorbidities: striving for complete recovery. Allgulander C; Kasper S Psychopharmacol Bull; 2002; 36 Suppl 2():103-11. PubMed ID: 12490826 [TBL] [Abstract][Full Text] [Related]
54. [Cymbalta in the treatment of chronic pain syndromes]. Odinak MM; Kashin AV; Ememlin AIu Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):32-4. PubMed ID: 19365388 [TBL] [Abstract][Full Text] [Related]
55. Doxepin as an adjunct in the treatment of chronic pain. Aronoff GM; Evans WO J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):42-7. PubMed ID: 7047506 [No Abstract] [Full Text] [Related]
56. Chronic pain: hypothesized mechanism and rationale for treatment. Gershon S Neuropsychobiology; 1986; 15 Suppl 1():22-7. PubMed ID: 2873527 [TBL] [Abstract][Full Text] [Related]
57. [Various comments on the antidepressive effect of Sandomigran]. Klapetek J Cesk Neurol Neurochir; 1976 Jul; 39(4):228-32. PubMed ID: 786480 [No Abstract] [Full Text] [Related]
58. Efficacy of milnacipran for glossodynia patients. Toyofuku A Int J Psychiatry Clin Pract; 2003; 7 Suppl 1():23-4. PubMed ID: 24937416 [TBL] [Abstract][Full Text] [Related]
59. [The clinicopsychological and therapeutic significance in the depression-pain relationship]. Chiriţa V; Chiriţa R; Cosmovici N; Mungiu OC; Pirozynski T Rev Med Chir Soc Med Nat Iasi; 1993; 97(2):257-60. PubMed ID: 7997667 [TBL] [Abstract][Full Text] [Related]
60. On the relationship between chronic pain and depression when there is no organic lesion. Magni G Pain; 1987 Oct; 31(1):1-21. PubMed ID: 3320879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]